On the public citation graph

Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (M pro ) of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

0 signed · 60 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1006/rwvi.1999.0055openalex-snapshot
CORONAVIRUSES (CORONAVIRIDAE)
inferredcites →https://doi.org/10.1007/s00213-020-05654-1openalex-snapshot
A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania
inferredcites →https://doi.org/10.1007/s11033-014-3417-xopenalex-snapshot
Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways
inferredcites →https://doi.org/10.1016/0014-5793(89)80109-7openalex-snapshot
Cysteine proteases of positive strand RNA viruses and chymotrypsin‐like serine proteases
inferredcites →https://doi.org/10.1016/j.apsb.2021.10.026openalex-snapshot
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
inferredcites →https://doi.org/10.1016/j.bioorg.2021.105455openalex-snapshot
The Mpro Structure-Based Modifications of Ebselen Derivatives for Improved Antiviral Activity Against SARS-CoV-2 Virus
inferredcites →https://doi.org/10.1016/j.chempr.2020.04.023openalex-snapshot
Chemistry and Biology of SARS-CoV-2
inferredcites →https://doi.org/10.1016/j.jmb.2006.11.073openalex-snapshot
Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein Overproduction
inferredcites →https://doi.org/10.1016/j.jmb.2006.11.078openalex-snapshot
Crystal Structures Reveal an Induced-fit Binding of a Substrate-like Aza-peptide Epoxide to SARS Coronavirus Main Peptidase
inferredcites →https://doi.org/10.1016/s0140-6736(17)31791-9openalex-snapshot
Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
inferredcites →https://doi.org/10.1016/s0140-6736(20)30251-8openalex-snapshot
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
inferredcites →https://doi.org/10.1021/acsptsci.0c00130openalex-snapshot
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV‑2 Main Protease Inhibitors
inferredcites →https://doi.org/10.1021/ol102027jopenalex-snapshot
Cu-Catalyzed Efficient Synthetic Methodology for Ebselen and Related Se−N Heterocycles
inferredcites →https://doi.org/10.1038/ncomms3748openalex-snapshot
Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen
inferredcites →https://doi.org/10.1038/s41467-021-23313-7openalex-snapshot
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
inferredcites →https://doi.org/10.1038/s41564-020-0695-zopenalex-snapshot
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
inferredcites →https://doi.org/10.1038/s41586-020-2223-yopenalex-snapshot
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
inferredcites →https://doi.org/10.1039/c4ob00027gopenalex-snapshot
An ebselen like catalyst with enhanced GPx activity via a selenol intermediate
inferredcites →https://doi.org/10.1073/pnas.1835675100openalex-snapshot
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
inferredcites →https://doi.org/10.1099/0022-1317-81-4-853openalex-snapshot
Virus-encoded proteinases and proteolytic processing in the Nidovirales
inferredcites →https://doi.org/10.1101/2022.03.29.486331openalex-snapshot
Genetic surveillance of SARS-CoV-2 M pro reveals high sequence and structural conservation prior to the introduction of protease inhibitor Paxlovid
inferredcites →https://doi.org/10.1107/s0907444904019158openalex-snapshot
Coot : model-building tools for molecular graphics
inferredcites →https://doi.org/10.1107/s0907444911001314openalex-snapshot
REFMAC 5 for the refinement of macromolecular crystal structures
inferredcites →https://doi.org/10.1107/s0907444994003112openalex-snapshot
The CCP4 suite: programs for protein crystallography
inferredcites →https://doi.org/10.1126/sciadv.abd0345openalex-snapshot
Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1126/science.1085658openalex-snapshot
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
inferredcites →https://doi.org/10.1126/science.abb3405openalex-snapshot
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
inferredcites →https://doi.org/10.1128/aac.00662-13openalex-snapshot
Interrogating a Hexokinase-Selected Small-Molecule Library for Inhibitors of Plasmodium falciparum Hexokinase
inferredcites →https://doi.org/10.1128/mbio.00869-22openalex-snapshot
Genetic Surveillance of SARS-CoV-2 M pro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
inferredcites →https://doi.org/10.1161/01.str.29.1.12openalex-snapshot
Ebselen in Acute Ischemic Stroke
inferredcites →https://doi.org/10.1371/journal.pbio.0030324openalex-snapshot
Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
inferredcites →https://doi.org/10.2147/hiv.s79956openalex-snapshot
HIV protease inhibitors: a review of molecular selectivity and toxicity
inferredcites →https://doi.org/10.2176/nmc.51.337openalex-snapshot
Neuroprotective Effects of Ebselen Following Forebrain Ischemia: Involvement of Glutamate and Nitric Oxide
inferredcites →https://doi.org/10.3205/id000034openalex-snapshot
Protease inhibitors for the treatment of hepatitis C virus infection

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/ajoc.202500093openalex-snapshot
Recent Advances in the Chemistry of 5 and 6‐Membered Selenacycles and Selenaheterocycles
inferred← citeshttps://doi.org/10.1002/jmv.29208openalex-snapshot
Discovery of the covalent SARS‐CoV‐2 Mpro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches
inferred← citeshttps://doi.org/10.1007/s13721-025-00521-5openalex-snapshot
Structural-based virtual screening of Ebselen derivatives to identify potential SARS-CoV-2 main protease inhibitors, utilizing 3D-QSAR models, molecular docking, MD simulation, and quantum mechanical calculations
inferred← citeshttps://doi.org/10.1016/bs.enz.2025.07.005openalex-snapshot
Coronaviruses main proteases and their inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2023.117531openalex-snapshot
Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115978openalex-snapshot
Design, synthesis and biological evaluation of biaryl amide derivatives against SARS-CoV-2 with dual-target mechanism
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116704openalex-snapshot
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
inferred← citeshttps://doi.org/10.1016/j.vetmic.2026.111192openalex-snapshot
Ebselen inhibits PRRSV replication by activating the TRIM16/SQSTM1–KEAP1–NRF2-mediated oxidative stress response pathway
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c02426openalex-snapshot
Selenization of Small Molecule Drugs: A New Player on the Board
inferred← citeshttps://doi.org/10.1038/s41392-025-02539-7openalex-snapshot
Antiviral drug discovery and development: challenges and future directions
inferred← citeshttps://doi.org/10.1038/s41580-023-00645-4openalex-snapshot
Understanding mechanisms of antioxidant action in health and disease
inferred← citeshttps://doi.org/10.1038/s41598-024-75519-6openalex-snapshot
New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides
inferred← citeshttps://doi.org/10.1038/s41598-025-28652-9openalex-snapshot
Broad-spectrum antiviral activity of ebselen
inferred← citeshttps://doi.org/10.1039/d2sc06584copenalex-snapshot
The impact of SARS-CoV-2 3CL protease mutations on nirmatrelvir inhibitory efficiency. Computational insights into potential resistance mechanisms
inferred← citeshttps://doi.org/10.1039/d5md00789eopenalex-snapshot
C6-Alkoxy substituted penicillins are potent non-covalently binding inhibitors of the SARS-CoV-2 main protease
inferred← citeshttps://doi.org/10.1042/bcj20230027openalex-snapshot
Key allosteric and active site residues of SARS-CoV-2 3CLpro are promising drug targets
inferred← citeshttps://doi.org/10.1042/bsr20231395openalex-snapshot
3-chymotrypsin-like protease in SARS-CoV-2
inferred← citeshttps://doi.org/10.1093/brain/awad432openalex-snapshot
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
inferred← citeshttps://doi.org/10.21203/rs.3.rs-5359235/v1openalex-snapshot
Discovery of Novel SARS-CoV-2 3CLpro Inhibitors from Natural Products by FRET-Based Assay
inferred← citeshttps://doi.org/10.2174/1389557523666230914103339openalex-snapshot
Ebselen: A Review on its Synthesis, Derivatives, Anticancer Efficacy and Utility in Combating SARS-COV-2
inferred← citeshttps://doi.org/10.3389/fphar.2024.1390705openalex-snapshot
Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals
inferred← citeshttps://doi.org/10.3389/fphar.2025.1599816openalex-snapshot
Synthetic and semi-synthetic antioxidants in medicine and food industry: a review
inferred← citeshttps://doi.org/10.3390/futurepharmacol4040044openalex-snapshot
Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
inferred← citeshttps://doi.org/10.3390/molecules28186696openalex-snapshot
Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.3390/ph16060834openalex-snapshot
A Tale of Two Proteases: MPro and TMPRSS2 as Targets for COVID-19 Therapies
inferred← citeshttps://doi.org/10.3390/vaccines11071222openalex-snapshot
Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.